Metabolites › KGYZXPBLSHLNAJ-MHPQWQMASA-N

6-O-(Glcb)-(25R)-5alpha-spirostan-3beta,6alpha-diol

(2R,4S,5S)-2-[[(3S,5S,6S,8R,9S,10R,13S,14S,16S,17R)-16-[(2S,5R)-2,5-dimethyloxan-2-yl]oxy-17-ethyl-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

KGYZXPBLSHLNAJ-MHPQWQMASA-N CHEBI:186851 0 Reactome links 2 studies
2 Observed studies
2 Observed diff profiles
0 Reactome pathways

Metabolite details

Identifier
KGYZXPBLSHLNAJ-MHPQWQMASA-N
InChI Key
KGYZXPBLSHLNAJ-MHPQWQMASA-N
IUPAC name
(2R,4S,5S)-2-[[(3S,5S,6S,8R,9S,10R,13S,14S,16S,17R)-16-[(2S,5R)-2,5-dimethyloxan-2-yl]oxy-17-ethyl-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
Preferred name
6-O-(Glcb)-(25R)-5alpha-spirostan-3beta,6alpha-diol
INN name
—
Synonym
—
ChEBI
CHEBI:186851

Reactome pathways

  • No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles